MENU 
The summary EQA timetable can be downloaded HERE. The calendar below includes all EQA open/close dates and other GenQA events.
EQA Catalogue Groups
(Click on a colour/icon to filter calendar entries)
Clinical Genetics and Genetic Counselling
Genomic and Inherited Disorders
Haematological Neoplasms
Individual Competency Assessment
Molecular Newborn Screening
Molecular Pathology
Multidisciplinary team (MDT) working
Pharmacogenomics
Preimplantation Genetic Testing (PGT)
Reproductive Genomics
Sample Handling
Technical (Next Generation Sequencing)
Variant Classification
Viral Sequencing
Other Events
GenQA EQA Enrolment Event
GenQA EQA Distribution Event
GenQA webinar
Conference
GenQA workshop
GenQA Participant meeting
GenQA office closed
Other
| «prev May 2026 next»
| ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| Sun 26 | Mon 27
2026 Distribution 4
2026 Ataxia & Hereditary Spastic Paraplegia (HSP) - OPENS Testing Period: 18 weeks
2026 Charcot Marie Tooth disease (CMT) and related sensory and motor neuropathies - OPENS Testing Period: 7 weeks
2026 Eye disorders - OPENS Testing Period: 7 weeks
2026 Familial colorectal cancer and polyposis - OPENS Testing Period: 18 weeks
2026 Familial endocrine tumour predisposition disorders - OPENS Testing Period: 7 weeks
2026 Familial Hypercholesterolaemia (FH) - OPENS Testing Period: 18 weeks
2026 Gastroenterology and hepatology disorders - OPENS Testing Period: 18 weeks
2026 Hereditary Breast and Ovarian Cancer (HBOC) disorders - OPENS Testing Period: 18 weeks
2026 Inborn Errors of Metabolism (IEM) - OPENS Testing Period: 18 weeks
2026 Mitochondrial disease - OPENS Testing Period: 18 weeks
2026 Muscular dystrophies - OPENS Testing Period: 18 weeks
2026 Neurodegenerative disorders - OPENS Testing Period: 18 weeks
2026 Neurofibromatosis and rasopathies - OPENS Testing Period: 7 weeks
2026 Parathyroid and Calcium Regulation disorders - OPENS Testing Period: 7 weeks
2026 Primary Immunodeficiency disorders (PID) - OPENS Testing Period: 18 weeks
2026 Skeletal dysplasia (including Osteogenesis Imperfecta) - OPENS Testing Period: 18 weeks
2026 Variant Validation - OPENS Testing Period: 18 weeks
2026 DNA quantification - OPENS Testing Period: 3 weeks | Tue 28 | Wed 29 | Thu 30
BRCA-HRR Variant Classification Run 16 CLOSES
| Fri 1 | Sat 2 |
| Sun 3 | Mon 4 | Tue 5 | Wed 6 | Thu 7 | Fri 8
2026 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) - round 1 - CLOSES
2026 MCADD Molecular Newborn Screening (bloodspots) - round 1 - CLOSES
2026 SCID Molecular Newborn Screening (bloodspots) - round 1 - CLOSES
2026 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) - round 1 - CLOSES | Sat 9 |
| Sun 10 | Mon 11
2026 Distribution 5
2026 Preimplantation genetic testing (PGT) of blastomere (FISH) - OPENS Testing Period: 3 weeks for Stage 1; 4 weeks for Stage 2 | Tue 12 | Wed 13 | Thu 14 | Fri 15
2026 DNA quantification - CLOSES
2026 Maternal cell contamination (MCC) & fetal sexing - CLOSES | Sat 16 |
| Sun 17 | Mon 18
2026 Distribution 6
2026 Clinical Genetics - dysmorphology - OPENS Testing Period: 6 weeks
2026 Genetic Counselling - oncogenetics - OPENS Testing Period: 6 weeks
2026 Genetic Counselling - rare and inherited disorders - OPENS Testing Period: 6 weeks
2026 Acute Lymphoblastic Leukaemia (ALL) - OPENS Testing Period: 6 weeks
2026 Haematological Technical FISH - OPENS Testing Period: 6 weeks
2026 Myeloid disorders - OPENS Testing Period: 6 weeks
2026 Myeloma - OPENS Testing Period: 6 weeks
2026 Microdeletion syndromes - OPENS Testing Period: 6 weeks
2026 Postnatal karyotyping - OPENS Testing Period: 6 weeks | Tue 19 | Wed 20 | Thu 21 | Fri 22 | Sat 23 |
| Sun 24 | Mon 25 | Tue 26
2026 Distribution 7
2026 Postnatal constitutional Copy Number Variant (CNV) detection - OPENS Testing Period: 8 weeks | Wed 27 | Thu 28 | Fri 29
2026 Colorectal cancer - core - CLOSES
2026 Colorectal cancer - MMR (MSI) - CLOSES
2026 Lung cancer - comprehensive (molecular) - CLOSES
2026 Lung cancer - EGFR only - CLOSES
2026 Melanoma - CLOSES
2026 Microsatellite instability testing (MSI) - CLOSES
2026 Chromosome instability syndromes - CLOSES
2026 Developmental Delay - CLOSES
2026 Differences in Sex Development (DSD) - CLOSES
2026 Hypotonic Infant - CLOSES
2026 Imprinting disorders - CLOSES
2026 Infertility - CLOSES
2026 Preimplantation genetic testing (PGT) of blastomere (FISH) - CLOSES | Sat 30 |
| Sun 31 | Mon 1
2026 Distribution 8
2026 Cystic Fibrosis (CF) and CFTR-related disorders - OPENS Testing Period: 7 weeks
2026 Fragile X syndrome and FMR1-related disorders - OPENS Testing Period: 7 weeks
2026 Huntington disease (HD) and DRPLA - OPENS Testing Period: 7 weeks
2026 Trio Sequencing - Postnatal (neonatal and paediatric) - OPENS Testing Period: 18 weeks
2026 X-inactivation - OPENS Testing Period: 7 weeks
2026 SARS-CoV-2 sequencing - Distribution 6055 - round 1 - OPENS Testing Period: 6 weeks from sample distribution | Tue 2 | Wed 3 | Thu 4 | Fri 5
2026 Cardiac disorders - CLOSES
2026 Epilepsy disorders - CLOSES
2026 Renal disorders - CLOSES
2026 Respiratory disorders - CLOSES | Sat 6 |
7872
NEWSLETTER SIGN UP